Loading...
•
Jun 30, 2024
TherapeuticsMD Q2 2024 Earnings Report
Reported financial results for the second quarter ended June 30, 2024.
Key Takeaways
TherapeuticsMD reported financial results for the second quarter ended June 30, 2024, focusing on license and service revenues as a pharmaceutical royalty company.
TherapeuticsMD is now a pharmaceutical royalty company.
The company primarily collects royalties from its licensees.
TherapeuticsMD is no longer engaging in research and development or commercial operations.
The company is evaluating strategic alternatives.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...